Skip to content

Gross margin at other companies

Artivion logo
ArtivionAORT
64.6%+0.6pp
AngioDynamics logo
AngioDynamicsANGO
54.3%-0.1pp
AIR
AirSculpt Technologies, Inc.AIRS
59.6%-0.3pp
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
64%+1.3pp
AtriCure logo
AtriCureATRC
75.6%+0.8pp
Haemonetics logo
HaemoneticsHAE
59%+4.0pp

Other financials

Income statement

See full
Revenue$12.5M+32.4%
Gross profit$7.5M-19.2%
Operating income-$5.5M-349%
Net income-$2.1M+48.6%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation

See full
Market cap$181.07M+114%
Enterprise value$189.4M+101%
P/S3.2×+1.4×

Profitability

See full
Operating margin-46%+9.9pp
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Return on equity-77.8%-22.4pp
Debt / equity3.1×-0.6×
Current ratio5.8×+0.3×

Where this comes from

Calculated from Apyx Medical Corporation’s reported figures.

Based on trailing twelve months.

The official record: Apyx Medical Corporation’s 10-Q, filed August 8, 2024, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apyx Medical Corporation's gross margin?
Apyx Medical Corporation (APYX) reported gross margin of 61.9% in Q2 2024.
How has Apyx Medical Corporation's gross margin changed year-over-year?
Apyx Medical Corporation's gross margin decreased by 4.8% year-over-year, from 65% to 61.9%.
What is the long-term trend for Apyx Medical Corporation's gross margin?
Over 3 years (2020 to 2023), Apyx Medical Corporation's gross margin has grown at a 0.7% compound annual growth rate (CAGR), from 63.2% to 64.5%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.